about
Novel anti-staphylococcal and anti-biofilm properties of two anti-malarial compounds: MMV665953 {1-(3-chloro-4-fluorophenyl)-3-(3,4-dichlorophenyl)urea} and MMV665807 {5-chloro-2-hydroxy-N-[3-(trifluoromethyl)phenyl]benzamide}.Evaluation of protein adsorption on atmospheric plasma deposited coatings exhibiting superhydrophilic to superhydrophobic properties.5-Hydroxyethyl-3-tetradecanoyltetramic acid represents a novel treatment for intravascular catheter infections due to Staphylococcus aureusMethicillin resistance alters the biofilm phenotype and attenuates virulence in Staphylococcus aureus device-associated infections.Staphylococcus epidermidis biofilms: importance and implications.icaR encodes a transcriptional repressor involved in environmental regulation of ica operon expression and biofilm formation in Staphylococcus epidermidis.Role for the A domain of unprocessed accumulation-associated protein (Aap) in the attachment phase of the Staphylococcus epidermidis biofilm phenotypeMethicillin resistance and the biofilm phenotype in Staphylococcus aureus.Methicillin resistance reduces the virulence of healthcare-associated methicillin-resistant Staphylococcus aureus by interfering with the agr quorum sensing system.The Possible Role of Staphylococcus epidermidis LPxTG Surface Protein SesC in Biofilm Formation.Untangling the Diverse and Redundant Mechanisms of Staphylococcus aureus Biofilm Formation.Convergence of Staphylococcus aureus Persister and Biofilm Research: Can Biofilms Be Defined as Communities of Adherent Persister Cells?The genetics of staphylococcal biofilm formation--will a greater understanding of pathogenesis lead to better management of device-related infection?A staphylococcal GGDEF domain protein regulates biofilm formation independently of cyclic dimeric GMPIn Vitro Approach for Identification of the Most Effective Agents for Antimicrobial Lock Therapy in the Treatment of Intravascular Catheter-Related Infections Caused by Staphylococcus aureus.Subdomains N2N3 of fibronectin binding protein A mediate Staphylococcus aureus biofilm formation and adherence to fibrinogen using distinct mechanisms.Eradication of Staphylococcus aureus Catheter-Related Biofilm Infections Using ML:8 and Citrox.AraC-Type Regulator Rbf Controls the Staphylococcus epidermidis Biofilm Phenotype by Negatively Regulating the icaADBC Repressor SarR.Rbf promotes biofilm formation by Staphylococcus aureus via repression of icaR, a negative regulator of icaADBC.Recombination-mediated remodelling of host-pathogen interactions during Staphylococcus aureus niche adaptation.Ventriculoperitoneal shunt-related infections caused by Staphylococcus epidermidis: pathogenesis and implications for treatment.Rapid quantitative and qualitative analysis of biofilm production by Staphylococcus epidermidis under static growth conditions.A novel Staphylococcus aureus biofilm phenotype mediated by the fibronectin-binding proteins, FnBPA and FnBPB.Tandem Amplification of the Staphylococcal Cassette Chromosome mec Element Can Drive High-Level Methicillin Resistance in Methicillin-Resistant Staphylococcus aureus.Potential use of targeted enzymatic agents in the treatment of Staphylococcus aureus biofilm-related infections.Redeploying β-Lactam Antibiotics as a Novel Antivirulence Strategy for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections.A unique SaeS allele overrides cell-density dependent expression of saeR and lukSF-PV in the ST30-SCCmecIV lineage of CA-MRSA.The major autolysin is redundant for Staphylococcus aureus USA300 LAC JE2 virulence in a murine device-related infection model.Inactivations of rsbU and sarA by IS256 represent novel mechanisms of biofilm phenotypic variation in Staphylococcus epidermidis.Into the storm: Chasing the opportunistic pathogen Staphylococcus aureus from skin colonisation to life-threatening infections.An Essential Role for Coagulase in Staphylococcus aureus Biofilm Development Reveals New Therapeutic Possibilities for Device-Related Infections.Oxacillin alters the toxin expression profile of community-associated methicillin-resistant Staphylococcus aureus.Role of surface protein SasG in biofilm formation by Staphylococcus aureus.Essential role for the major autolysin in the fibronectin-binding protein-mediated Staphylococcus aureus biofilm phenotype.Anti-biofilm activity of sub-inhibitory povidone-iodine concentrations against Staphylococcus epidermidis and Staphylococcus aureus.Oxygen-mediated regulation of biofilm development is controlled by the alternative sigma factor sigma(B) in Staphylococcus epidermidis.Genomic diversity of Staphylococcus epidermidis isolates from the intensive care unit.Rapid depletion of dissolved oxygen in 96-well microtiter plate Staphylococcus epidermidis biofilm assays promotes biofilm development and is influenced by inoculum cell concentration.Environmental regulation of biofilm formation in intensive care unit isolates of Staphylococcus epidermidis.Biofilm and the role of the ica operon and aap in Staphylococcus epidermidis isolates causing neurosurgical meningitis.
P50
Q30491192-EB8D4BB6-4174-47DE-9E47-8CACB7125061Q33454486-E47DA224-5C85-45A1-ADB6-663F1E3D9D7CQ33589815-327ACD68-EE06-4B17-9D6E-68BAD0FB654EQ34229656-33F936DD-6533-45D7-9F31-97E2FAA08C23Q34303524-38B0EE1D-2AA2-462F-A7BE-01288945D30AQ34316746-8747D4F1-DFE0-460E-9F5B-2FD495B85A1CQ34593431-62010D6D-A338-4B44-A417-ED383E59499FQ35022299-0D789D0D-D800-4CA4-AF5D-FB344781809FQ35868125-D2ABF183-9642-42D7-B15C-818C3912A18EQ35901094-98CB1EF9-F558-4994-971E-31B13F8342B5Q36083432-33E291D6-49BC-4E1E-BB4D-C101C5B29B8BQ36235720-9FA912EF-AB17-40E3-A140-9CCC740D2E42Q36322215-C08F7733-7E30-4DAD-9E81-DD9D05898682Q36804411-AB01C5A0-8DB1-4D3E-BD2E-2C61E5516FE6Q36888073-7611C760-FD8A-4CD6-8E66-D8CFD58BA3D0Q36911562-324E96EF-9F5A-490B-9E34-691135149656Q37287744-BCB1482B-1F69-4E11-AC8F-F26BFE4B3BDCQ37321985-18B1710D-D384-40B1-90DB-9391B8478D8FQ37365249-694297EA-935A-40DD-BB50-B39F8F21CD4EQ37658150-15BBC638-297A-42CC-8253-DEEC52478931Q37981218-09EC1033-2732-4A05-A0B8-49F145A5AFDBQ38403231-4159D616-308B-4471-8848-211CD66749A5Q38608812-654615B2-086E-4FDE-A426-AFBECCC69F9AQ38674792-38C562E7-83FD-4BE0-A23D-63CACC1D567CQ38870588-FCE6CC5B-F5AD-4B1A-ABB9-297A393BDD9AQ39026201-12F8A795-A12A-4EBB-9924-08A42B4CBB6FQ39707903-03117B0C-7B32-4863-8521-AB22AC6486DFQ39864232-FB91494A-A704-4579-9EE5-79009ED8B322Q39963838-DB6395A9-B749-4BC3-A04B-78B9A873321EQ40165712-47510777-75F6-426E-8F3E-D625F6A58DECQ41184570-06AD0459-30CB-47D6-B43B-6F07EDB389A3Q41907581-BBA01B4D-728A-4935-BB75-FE0396B39591Q42067303-B5ACB713-B5D6-476C-87C3-26D0FBFD020DQ42706688-66EB8BBD-F69C-46C2-B335-9CAA3FBB984DQ43148418-1D6F4F9F-C1E8-43D6-A660-17038055C134Q43215446-A35421F3-C790-4E9D-BA37-53EA80D51C1AQ43411160-622252B9-21A7-4481-A515-85DC71BEDC11Q43665368-A195612F-ED45-400B-BD86-F0371CF4B9D6Q44207003-B3D6235C-C6EF-4308-BDD9-9D34AE8025C6Q44552605-07180872-DA0E-4979-AD8A-E2F56D1A43AC
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
James P O'Gara
@ast
James P O'Gara
@en
James P O'Gara
@es
James P O'Gara
@nl
type
label
James P O'Gara
@ast
James P O'Gara
@en
James P O'Gara
@es
James P O'Gara
@nl
prefLabel
James P O'Gara
@ast
James P O'Gara
@en
James P O'Gara
@es
James P O'Gara
@nl
P108
P106
P31
P496
0000-0003-3866-7161